My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Substances
Tesamorelin

Tesamorelin

A-Z
Search for:
Tesamorelin
Dragon Pharma
Tesamorelin 2
Ultima Pharmaceuticals
TESAMORELIN
Euro-Pharmacies
Tesamorelin 5
Ultima Pharmaceuticals
Tesamorelin
Beligas Pharmaceuticals
Substance Overview and History

Tesamorelin is a synthetic version of GHRH that is growth hormone releasing hormone. Firstly created by Valeant Pharmaceuticals. In 2000 it was licensed by Theratechnologies . They keep managed its further clinical trials and advancements. In 2010 the drug was approved by the USA FDA under the trade name Egrifta for the treatment of HIV-associated lipodystrophy. Canada followed with approval in 2015. In performance-enhancing spectrum Tesamorelin has been observed to significantly reduce fat mass and provide moderate gains in lean body mass when used for physique or performance enhancement.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ
What is Tesamorelin used for?
Tesamorelin is primarily prescribed for the treatment of HIV-related lipodystrophy and It is approved under the trade name Egrifta.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How does Tesamorelin work?
Tesamorelin stimulates the pituitary gland to release growth hormone, which increases level of IGF-1, leading to fat loss and supports muscle growth.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What are the side effects of Tesamorelin?
The side effects are generally mild but common include joint pain, swelling, redness at the injection site, and increased blood sugar levels. Additionally it may have effects on growth hormone levels, which should be monitored during use.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.